The Anti-leukemic Activities of Campesterol and Α-Tocopherol Against BCL-2 Target through Computational Drug Design Approaches
Campesterol and α-tocopherol are promising BCL-2 inhibitors that might become effective anti-leukemic therapies with additional <i>in vitro</i> and <i>in vivo</i> research.
Authors
- Neeraj Kumar (ORCID: https://orcid.org/0000-0001-5508-0616)
- Mohammed Bourhia (ORCID: https://orcid.org/0000-0003-3707-8461)
- Yousef A. Bin Jardan (ORCID: https://orcid.org/0000-0003-3302-4036)
- Haruna Isiyaku Umar (ORCID: https://orcid.org/0000-0001-9427-9804)
- Christopher Busayo Olowosoke (ORCID: https://orcid.org/0000-0002-4315-3184)
- Najwa Ahmad Kuthi
- Omoboyede Victor
- Idayat Oyinkansola Kehinde
- Tomilola Victor Akingbade (ORCID: https://orcid.org/0009-0004-3295-8851)
- Oluwayemisi Titobioluwa Agbeniyi
- Yinka Okunola
Institutions
- Khulna University (BD)
- Federal University of Technology (NG)
- University of Ibadan (NG)
- United States Military Academy (US)
- King Saud University (SA)
- Rabindranath Tagore Medical College (IN)
- Université Ibn Zohr (MA)
- University of Technology Malaysia (MY)
- Nigerian Institute of Medical Research (NG)
Publication Details
- Journal
- Current Topics in Medicinal Chemistry
- Published
- 2024-10-14
- DOI
- https://doi.org/10.2174/0115680266316570240926081647
- Citations
- 1
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.36